Article info

Download PDFPDF

Original research
Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme

Authors

  1. Correspondence to Lisy Wang; Lisy.Wang{at}Pfizer.com
View Full Text

Citation

Cohen SB, Tanaka Y, Mariette X, et al
Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme

Publication history

  • Received July 13, 2020
  • Revision received September 28, 2020
  • Accepted September 29, 2020
  • First published October 30, 2020.
Online issue publication 
October 30, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.